Literature DB >> 29220556

Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity.

Fredrik Wallentin1, Björn Wettermark2,3, Thomas Kahan1.   

Abstract

The authors investigated antihypertensive drug treatment in Sweden using the Stockholm Regional Healthcare Data Warehouse, providing information on all healthcare consultations, diagnoses, hospitalizations, dispensed prescription drugs, sex, and age in 2.1 million persons. This cross-sectional analysis identified 292 428 individuals 20 years or older with hypertension (mean age 68 ± 13 years, 53% women). About half had no diabetes mellitus or cardiovascular comorbidity. The number of dispensed drugs was lower in women than in men (1.9 ± 1.3 vs 2.1 ± 1.5, P < .001). Women more often used diuretics, angiotensin receptor blockers, and β-blockers, while men used more angiotensin-converting enzyme inhibitors and calcium channel blockers (all P < .01). In women, 66% with diabetes mellitus and 72% with heart failure used angiotensin-converting enzyme inhibitors/angiotensin receptor blockers vs 76% and 79% in men (all P < .001, adjusted for age and comorbidity). Thus, sex differences in treatment prevail. There is room for improvement, which could reduce cardiovascular complications. ©2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  antihypertensive agents; blood pressure; cardiovascular disease; diabetes mellitus; hypertension; primary health care; sex; treatment

Mesh:

Substances:

Year:  2017        PMID: 29220556      PMCID: PMC8031007          DOI: 10.1111/jch.13149

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  40 in total

1.  Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment.

Authors:  Björn Wettermark; Brian Godman; Martin Neovius; Niklas Hedberg; Tor-Olov Mellgren; Thomas Kahan
Journal:  Health Policy       Date:  2009-10-29       Impact factor: 2.980

2.  Protective effects of antihypertensive treatment in patients aged 85 years or older.

Authors:  Giovanni Corrao; Federico Rea; Matteo Monzio Compagnoni; Luca Merlino; Giuseppe Mancia
Journal:  J Hypertens       Date:  2017-07       Impact factor: 4.844

Review 3.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

4.  Trends in Antihypertensive Medication Use and Blood Pressure Control Among Adults With Hypertension in Germany.

Authors:  Giselle Sarganas; Hildtraud Knopf; Daniel Grams; Hannelore K Neuhauser
Journal:  Am J Hypertens       Date:  2015-05-11       Impact factor: 2.689

5.  Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD).

Authors:  C Ljungman; T Kahan; L Schiöler; P Hjerpe; B Wettermark; K B Boström; K Manhem
Journal:  J Hum Hypertens       Date:  2014-11-06       Impact factor: 3.012

6.  High remaining risk in poorly treated hypertension: the 'rule of halves' still exists.

Authors:  Lars Weinehall; Bengt Ohgren; Mats Persson; Birgitta Stegmayr; Kurt Boman; Göran Hallmans; Lars H Lindholm
Journal:  J Hypertens       Date:  2002-10       Impact factor: 4.844

7.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

8.  Treatment of hypertension in patients 80 years of age or older.

Authors:  Nigel S Beckett; Ruth Peters; Astrid E Fletcher; Jan A Staessen; Lisheng Liu; Dan Dumitrascu; Vassil Stoyanovsky; Riitta L Antikainen; Yuri Nikitin; Craig Anderson; Alli Belhani; Françoise Forette; Chakravarthi Rajkumar; Lutgarde Thijs; Winston Banya; Christopher J Bulpitt
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

Review 9.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Authors:  M R Law; J K Morris; N J Wald
Journal:  BMJ       Date:  2009-05-19

10.  High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health.

Authors:  Axel C Carlsson; Per Wändell; Urban Ösby; Ramin Zarrinkoub; Björn Wettermark; Gunnar Ljunggren
Journal:  BMC Public Health       Date:  2013-07-18       Impact factor: 3.295

View more
  8 in total

1.  Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity.

Authors:  Fredrik Wallentin; Björn Wettermark; Thomas Kahan
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-08       Impact factor: 3.738

2.  Antihypertensive drug treatment: the real-life challenge.

Authors:  Konstantinos P Imprialos; Konstantinos Stavropoulos; Michael Doumas
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-08       Impact factor: 3.738

3.  Replicating medication trend studies using ad hoc information extraction in a clinical data warehouse.

Authors:  Georg Dietrich; Jonathan Krebs; Leon Liman; Georg Fette; Maximilian Ertl; Mathias Kaspar; Stefan Störk; Frank Puppe
Journal:  BMC Med Inform Decis Mak       Date:  2019-01-18       Impact factor: 2.796

4.  Efficacy evaluation of serum galectin-3 in hypertension complicated with diastolic dysfunction.

Authors:  Tianwei Dong; Hongbin Li; Shuang Wang; Weida Chen
Journal:  Exp Ther Med       Date:  2019-11-18       Impact factor: 2.447

5.  Socioeconomic status affects achievement of blood pressure target in hypertension: contemporary results from the Swedish primary care cardiovascular database.

Authors:  Georgios Mourtzinis; Karin Manhem; Thomas Kahan; Linus Schiöler; Jetish Isufi; Charlotta Ljungman; Tobias Andersson; Per Hjerpe
Journal:  Scand J Prim Health Care       Date:  2021-11-24       Impact factor: 2.581

6.  Exploring gender differences in medication consumption and mortality in a cohort of hypertensive patients in Northern Italy.

Authors:  David Consolazio; Maria Elena Gattoni; Antonio Giampiero Russo
Journal:  BMC Public Health       Date:  2022-04-15       Impact factor: 4.135

7.  Initiation of antihypertensive drugs to patients with confirmed COVID-19-A population-based cohort study in Sweden.

Authors:  Salar Issa Mousa; Fredrik Nyberg; Mohammadhossein Hajiebrahimi; Rebecka Bertilsson; Jonatan Nåtman; Ailiana Santosa; Björn Wettermark
Journal:  Basic Clin Pharmacol Toxicol       Date:  2022-07-06       Impact factor: 3.688

8.  Effectiveness by gender and age of renin-angiotensin system blockade in heart failure-A national register-based cohort study.

Authors:  Anna Ohlsson; Bertil Lindahl; Ronnie Pingel; Marianne Hanning; Ragnar Westerling
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-02-17       Impact factor: 2.890

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.